research-student

Publications

Recent peer-reviewed original studies and book publications (2014-2016)

  1. Mohamoud YA, Riome S,  Abu-Raddad LJ. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. Int J Infect Dis 2016;46:116-25.
  2. Omori R,  Abu-Raddad LJ. Population sexual behavior and HIV prevalence in Sub-Saharan Africa: missing links? Int J Infect Dis 2016;44:1-3.
  3. Humphrey JM, Glesby MJ,  Abu-Raddad LJ. MENA’s Zika-free status relies on a wing and a prayer. Nature Middle East 2016;doi:10.1038/nmiddleeast.2016.35; Online paper. (Commentary)
  4. Chaabna K, Kouyoumjian SP,  Abu-Raddad LJ. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PLOS ONE 2016;11:e0149966.
  5. Heijnen M, Mumtaz GR,  Abu-Raddad LJ. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis. Journal of the International AIDS Society 2016;19:20873.
  6. Cuadros DF, Miller FD, Nagelkerke N,  Abu-Raddad LJ. Association between HCV infection and diabetes type 2 in Egypt: Is it time to split up? Annals of Epidemiology 2015;25:918-23.
  7. Chemaitelly H, Mahmud S, Rahmani AM,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis. International Journal of Infectious Diseases 2015;40:54-63.
  8. Omori R, Chemaitelly H,  Abu-Raddad LJ. Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission. Sexually Transmitted Infections 2015;91:451-7.
  9. Awad SF, Sgaier SK, Ncube G, Xaba S, Mugurungi O, Mhangara M, Lau FK, Mohamoud YA,  Abu-Raddad LJ. A reevaluation of the voluntary medical male circumcision scale-up plan in Zimbabwe. PLOS ONE 2015;10:e0140818.
  10. Fadlalla FA, Mohamoud YA, Mumtaz GR,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses. PLOS ONE 2015;10:e0121873.
  11. Abu-Raddad LJ. Role of acute HIV infection in driving HIV transmission: Implications for HIV treatment as prevention. PLOS Medicine 2015;12:e1001803. (Invited Perspective)
  12. Benova L, Awad SF, Miller FD,  Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015;61:834-42.
  13. Chemaitelly H,  Abu-Raddad LJ. Characterizing HIV epidemiology in stable couples in Cambodia, the Dominican Republic, Haiti, and India. Epidemiology and Infection 2015;144:90-6.
  14. Abu-Raddad LJ. Cost-effectiveness of community-based strategies for HIV. The Lancet HIV 2015;2:e122-e3. (Invited Comment)
  15. Awad SF, Sgaier SK, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, Njeuhmeli E,  Abu-Raddad LJ. Investigating voluntary medical male circumcision program efficiency gains through subpopulation prioritization: insights from application to Zambia. PLOS ONE 2015;10:e0145729.
  16. Chemaitelly H, Chaabna K,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Fertile Crescent: systematic review and meta-analysis. PLOS ONE 2015;10:e0135281.
  17. Cuadros DF, Branscum A, Miller FD, Awad SF,  Abu-Raddad LJ. Are geographical "cold spots" of male circumcision driving differential HIV dynamics in Tanzania? Frontiers in Public Health 2015;3:218.
  18. Mumtaz GR, Weiss HA, Vickerman P, Larke N,  Abu-Raddad LJ. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa. AIDS 2015;29:1701-10.
  19. Mumtaz GR, Weiss HA,  Abu-Raddad LJ. Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden? Journal of the International AIDS Society 2015;18:20582. (Invited Viewpoint)
  20. Nagelkerke N,  Abu-Raddad LJ. On the history of Ebola and viral hemorrhagic fevers. Nature Middle East 2015;doi: 10.1038/nmiddleeast.2015.75; Online paper. (Commentary)
  21. Mohamoud YA, Miller FD,  Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker. World Journal of Gastroenterology 2014;20:12734-52.
  22. Benova L, Mohamoud YA, Calvert C,  Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical Infectious Diseases 2014;59:765-73.
  23. Cuadros DF, Branscum AJ, Miller FD,  Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications. Hepatology 2014;60:1150-9.
  24. Awad SF, Tambatamba BC, Kaonga A, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zambia. Republic of Zambia: Ministry of Community Development and Mother and Child Health; 2014.
  25. Bennani A, Latifi A, El Kettani A, Maaroufi A, Guezzar F, Alami K, El Rhilani H, El Omari B, Kouyoumjian PS, Haddad P,  Abu-Raddad LJ. National and Souss Massa Draa: HIV modes of transmission analysis in Morocco 2013. Morocco Ministry of Health & Joint United Nations Programme on HIV/AIDS; 2014.
  26. Abu-Raddad LJ,  Awad SF. How does population viral load vary with the evolution of a large HIV epidemic in sub-Saharan Africa? AIDS 2014;28:927-9.
  27. Chemaitelly H, Awad SF,  Abu-Raddad LJ. The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa. Epidemics 2014;6:1-9.
  28. Mumtaz GR, Riedner G,  Abu-Raddad LJ. The emerging face of the HIV epidemic in the Middle East and North Africa. Current Opinion in HIV and AIDS 2014;9:183-91. (Invited Review)
  29. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D,  Abu-Raddad LJ. HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLOS Medicine 2014;11:e1001663.
  30. Cuadros DF,  Abu-Raddad LJ. Spatial variability in HIV prevalence declines in several countries in sub-Saharan Africa. Health & Place 2014;28:45-9.
  31. Chemaitelly H, Awad SF, Shelton JD,  Abu-Raddad LJ. Sources of HIV incidence among stable couples in sub-Saharan Africa. Journal of the International AIDS Society 2014;17:18765.
  32. Awad SF, Ncube G, Xaba S, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zimbabwe. Republic of Zimbabwe: Ministry of Health and Child Care; 2014.
  33. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR,  Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Systematic Reviews 2014;3:146. (Peer-reviewed Methodology Protocol)
  34. Cuadros DF, Abu-Raddad LJ, Awad SF,  Garcia-Ramos G. Use of agent-based simulations to design and interpret HIV clinical trials. Computers in Biology and Medicine 2014;50:1-8.
  35. Verjee MA, Haddad P, Laws Sa,  Abu-Raddad LJ. Organ donation and transplantation: A gender perspective and awareness survey in Qatar. Journal of Local and Global Health Science 2014;2014:6.
  36. Bansal D, Elmi AA, Skariah S, Haddad P, Abu-Raddad LJ, Al Hamadi AH, Mohamed-Nady N, Affifi NM, Ghedira R, Hassen E, Al-Thani AAJ, Al-Ansari AAHM,  Sultan AA. Molecular epidemiology and genotype distribution of human papillomavirus (HPV) among Arab women in the State of Qatar. Journal of Translational Medicine 2014;12:300.
  37. Awad SF,  Abu-Raddad LJ. Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s? Epidemics 2014;8:9-17.
  38. Abu-Raddad LJ,  Nagelkerke N. Biomarkers for sexual behaviour change: a role for nonpaternity studies? AIDS 2014;28:1243-5. (Correspondance/Commentary)
  39. Christos PJ, Chemaitelly H, Abu-Raddad LJ, Zirie MA, Deleu D,  Mushlin AI. Prevention of type II diabetes mellitus in Qatar: Who is at risk? Qatar Medical Journal 2014;13.

Publications in high-impact journals

  1. Benova L, Awad SF, Miller FD, Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015;61:834-42.
  2. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical Infectious Diseases 2014;59:765-73.
  3. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications. Hepatology 2014;60:1150-9.
  4. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D,  Abu-Raddad LJ. HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLOS Medicine 2014;11:e1001663.
  5. Mumtaz G, Hilmi N, McFarland W, Kaplan RL, Akala FA, Semini I, Riedner G, Tawil O, Wilson D,  Abu-Raddad LJ. Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis. PLOS Medicine 2011;8:e1000444.
  6. Schiffer JT, Abu-Raddad LJ, Mark KE, Zhu J, Selke S, Koelle DM, Wald A,  Corey L. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proceedings of the National Academy of Sciences of the United States of America 2010;107:18973-8.
  7. Miller FD,  Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the National Academy of Sciences of the United States of America2010;107:14757-62.
  8. Schiffer JT, Abu-Raddad LJ, Mark KE, Zhu J, Selke S, Magaret A, Wald A,  Corey L. Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model. Science Translational Medicine 2009;1:7ra16.
  9. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Jr., Dye C,  Halloran ME. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America2009;106:13980-5.
  10. Hankins C, Hargrove J, Williams B, Abu-Raddad LJ, Auvert B, Bollinger L, Dorrington R, Ghani A, Gray R, Hallett T, Kahn JG, Lohse N, Nagelkerke N, Porco T, Schmid G, Stover J, Weiss H, Welte A, White P, White R,  Mod UWSEG. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLOS Medicine 2009;6. (Peer-reviewed Policy Forum)
  11. Boily MC, Abu-Raddad L, Desai K, Masse B, Self S,  Anderson R. Measuring the public-health impact of candidate HIV vaccines as part of the licensing process. The Lancet Infectious Diseases2008;8:200-7. (Peer-reviewed Personal View)
  12. Abu-Raddad LJ, van der Ventel BI,  Ferguson NM. Interactions of multiple strain pathogen diseases in the presence of coinfection, cross immunity, and arbitrary strain diversity. Phys Rev Lett2008;100:168102.
  13. Abu-Raddad LJ, Patnaik P,  Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006;314:1603-6.
  14. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM,  Anderson RM. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.
  15. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, Leung GM, Ho LM, Lam TH, Thach TQ, Chau P, Chan KP, Lo SV, Leung PY, Tsang T, Ho W, Lee KH, Lau EM, Ferguson NM,  Anderson RM. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003;300:1961-6.

List of all journal publications

  1. Mohamoud YA, Riome S,  Abu-Raddad LJ. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. Int J Infect Dis 2016;46:116-25.
  2. Omori R,  Abu-Raddad LJ. Population sexual behavior and HIV prevalence in Sub-Saharan Africa: missing links? Int J Infect Dis 2016;44:1-3.
  3. Humphrey JM, Glesby MJ,  Abu-Raddad LJ. MENA’s Zika-free status relies on a wing and a prayer. Nature Middle East 2016;doi:10.1038/nmiddleeast.2016.35; Online paper. (Commentary)
  4. Chaabna K, Kouyoumjian SP,  Abu-Raddad LJ. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PLOS ONE 2016;11:e0149966.
  5. Heijnen M, Mumtaz GR,  Abu-Raddad LJ. Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis. Journal of the International AIDS Society 2016;19:20873.
  6. Cuadros DF, Miller FD, Nagelkerke N,  Abu-Raddad LJ. Association between HCV infection and diabetes type 2 in Egypt: Is it time to split up? Annals of Epidemiology 2015;25:918-23.
  7. Chemaitelly H, Mahmud S, Rahmani AM,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis. International Journal of Infectious Diseases 2015;40:54-63.
  8. Omori R, Chemaitelly H,  Abu-Raddad LJ. Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission. Sexually Transmitted Infections 2015;91:451-7.
  9. Awad SF, Sgaier SK, Ncube G, Xaba S, Mugurungi O, Mhangara M, Lau FK, Mohamoud YA,  Abu-Raddad LJ. A reevaluation of the voluntary medical male circumcision scale-up plan in Zimbabwe. PLOS ONE 2015;10:e0140818.
  10. Fadlalla FA, Mohamoud YA, Mumtaz GR,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses. PLOS ONE 2015;10:e0121873.
  11. Abu-Raddad LJ. Role of acute HIV infection in driving HIV transmission: Implications for HIV treatment as prevention. PLOS Medicine 2015;12:e1001803. (Invited Perspective)
  12. Chemaitelly H,  Abu-Raddad LJ. Characterizing HIV epidemiology in stable couples in Cambodia, the Dominican Republic, Haiti, and India. Epidemiology and Infection 2015;144:90-6.
  13. Abu-Raddad LJ. Cost-effectiveness of community-based strategies for HIV. The Lancet HIV 2015;2:e122-e3. (Invited Comment)
  14. Awad SF, Sgaier SK, Tambatamba BC, Mohamoud YA, Lau FK, Reed JB, Njeuhmeli E,  Abu-Raddad LJ. Investigating voluntary medical male circumcision program efficiency gains through subpopulation prioritization: insights from application to Zambia. PLOS ONE 2015;10:e0145729.
  15. Chemaitelly H, Chaabna K,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Fertile Crescent: systematic review and meta-analysis. PLOS ONE 2015;10:e0135281.
  16. Cuadros DF, Branscum A, Miller FD, Awad SF,  Abu-Raddad LJ. Are geographical "cold spots" of male circumcision driving differential HIV dynamics in Tanzania? Frontiers in Public Health 2015;3:218.
  17. Mumtaz GR, Weiss HA, Vickerman P, Larke N,  Abu-Raddad LJ. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa. AIDS 2015;29:1701-10.
  18. Mumtaz GR, Weiss HA,  Abu-Raddad LJ. Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden? Journal of the International AIDS Society 2015;18:20582. (Invited Viewpoint)
  19. Nagelkerke N,  Abu-Raddad LJ. On the history of Ebola and viral hemorrhagic fevers. Nature Middle East 2015;doi: 10.1038/nmiddleeast.2015.75; Online paper. (Commentary)
  20. Mohamoud YA, Miller FD,  Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker. World Journal of Gastroenterology 2014;20:12734-52.
  21. Awad SF, Tambatamba BC, Kaonga A, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zambia. Republic of Zambia: Ministry of Community Development and Mother and Child Health; 2014.
  22. Bennani A, Latifi A, El Kettani A, Maaroufi A, Guezzar F, Alami K, El Rhilani H, El Omari B, Kouyoumjian PS, Haddad P,  Abu-Raddad LJ. National and Souss Massa Draa: HIV modes of transmission analysis in Morocco 2013. Morocco Ministry of Health & Joint United Nations Programme on HIV/AIDS; 2014.
  23. Abu-Raddad LJ,  Awad SF. How does population viral load vary with the evolution of a large HIV epidemic in sub-Saharan Africa? AIDS 2014;28:927-9.
  24. Chemaitelly H, Awad SF,  Abu-Raddad LJ. The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa. Epidemics 2014;6:1-9.
  25. Mumtaz GR, Riedner G,  Abu-Raddad LJ. The emerging face of the HIV epidemic in the Middle East and North Africa. Current Opinion in HIV and AIDS 2014;9:183-91. (Invited Review)
  26. Cuadros DF,  Abu-Raddad LJ. Spatial variability in HIV prevalence declines in several countries in sub-Saharan Africa. Health & Place 2014;28:45-9.
  27. Chemaitelly H, Awad SF, Shelton JD,  Abu-Raddad LJ. Sources of HIV incidence among stable couples in sub-Saharan Africa. Journal of the International AIDS Society 2014;17:18765.
  28. Awad SF, Ncube G, Xaba S, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zimbabwe. Republic of Zimbabwe: Ministry of Health and Child Care; 2014.
  29. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR,  Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Systematic Reviews 2014;3:146. (Peer-reviewed Methodology Protocol)
  30. Cuadros DF, Abu-Raddad LJ, Awad SF,  Garcia-Ramos G. Use of agent-based simulations to design and interpret HIV clinical trials. Computers in Biology and Medicine 2014;50:1-8.
  31. Verjee MA, Haddad P, Laws Sa,  Abu-Raddad LJ. Organ donation and transplantation: A gender perspective and awareness survey in Qatar. Journal of Local and Global Health Science 2014;2014:6.
  32. Bansal D, Elmi AA, Skariah S, Haddad P, Abu-Raddad LJ, Al Hamadi AH, Mohamed-Nady N, Affifi NM, Ghedira R, Hassen E, Al-Thani AAJ, Al-Ansari AAHM,  Sultan AA. Molecular epidemiology and genotype distribution of human papillomavirus (HPV) among Arab women in the State of Qatar. Journal of Translational Medicine 2014;12:300.
  33. Awad SF,  Abu-Raddad LJ. Could there have been substantial declines in sexual risk behavior across sub-Saharan Africa in the mid-1990s? Epidemics 2014;8:9-17.
  34. Abu-Raddad LJ,  Nagelkerke N. Biomarkers for sexual behaviour change: a role for nonpaternity studies? AIDS 2014;28:1243-5. (Correspondance/Commentary)
  35. Christos PJ, Chemaitelly H, Abu-Raddad LJ, Zirie MA, Deleu D,  Mushlin AI. Prevention of type II diabetes mellitus in Qatar: Who is at risk? Qatar Medical Journal 2014;13.
  36. Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM, Jr.,  Wasserheit JN. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS 2013;27:2494-6. (Letter to the Editor)
  37. Miller FD,  Abu-Raddad LJ. Quantifying current hepatitis C virus incidence in Egypt. Journal of Viral Hepatitis 2013;20:666-7. (Letter to the Editor/Commentary)
  38. Abu-Raddad LJ, Ghanem KG, Feizzadeh A, Setayesh H, Calleja JMG,  Riedner G. HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress? Sexually Transmitted Infections 2013;89:iii1-iii4. (Editorial)
  39. Al-Thani A, Abdul-Rahim H, Alabsi E, Bsaisu HN, Haddad P, Mumtaz GR,  Abu-Raddad LJ. Prevalence of Chlamydia trachomatis infection in the general population of women in Qatar. Sexually Transmitted Infections 2013;89:iii57-iii60.
  40. Mumtaz GR, Kouyoumjian SP, Hilmi N, Zidouh A, Rhilani HE, Alami K, Bennani A, Gouws E, Ghys PD,  Abu-Raddad LJ. The distribution of new HIV infections by mode of exposure in Morocco. Sexually Transmitted Infections 2013;89:iii49-iii56.
  41. Saba HF, Kouyoumjian SP, Mumtaz GR,  Abu-Raddad LJ. Characterising the progress in HIV/AIDS research in the Middle East and North Africa. Sexually Transmitted Infections 2013;89:iii5-iii9.
  42. Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IM, Jr., Wasserheit JN,  Group HIVVLW. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? AIDS 2013;27:981-9.
  43. Chemaitelly H,  Abu-Raddad LJ. External infections contribute minimally to HIV incidence among HIV sero-discordant couples in sub-Saharan Africa. Sexually Transmitted Infections 2013;89:138-41.
  44. Kouyoumjian SP, Mumtaz GR, Hilmi N, Zidouh A, El Rhilani H, Alami K, Bennani A, Gouws E, Ghys PD,  Abu-Raddad LJ. The epidemiology of HIV infection in Morocco: systematic review and data synthesis. International Journal of STD & AIDS 2013;24:507-16.
  45. Chemaitelly H, Shelton JD, Hallett TB,  Abu-Raddad LJ. Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS 2013;27:251-60.
  46. Abu-Raddad LJ, Chemaitelly H,  Mumtaz G. A regional picture: MENA's HIV map. Nature Middle East 2013;DOI: 10.1038/nmiddleeast.2013.229. (Invited Commentary)
  47. Christos PJ, Chemaitelly H, Abu-Raddad LJ, Gehani AR, Deleu D,  Mushlin AI. Prevention during the epidemiologic shift to chronic illness: a case control study of risk factors associated with cardiovascular disease in Qatar. Journal of Local and Global Health Perspectives 2013:4.
  48. Mohamoud YA, Cuadros DF,  Abu-Raddad LJ. Characterizing the Copts in Egypt: Demographic, socioeconomic and health indicators. QScience Connect 2013:22.
  49. Abu-Raddad LJ, Sgaier SK,  Mumtaz GR. HIV response in the Middle East and North Africa: An epidemic and its policy dilemmas. In: Smith R, ed. Global HIV/AIDS Politics, Policy and Activism: Persistent Challenges and Emerging Issues. Washington DC: Praeger Publishers; 2013:143-68.
  50. Abu-Raddad LJ, Barnabas RV, Janes H, Weiss HA, Kublin JG, Longini IMJ,  Wasserheit JN. Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'. AIDS 2013;27:2826-7. (Letter to the Editor)
  51. Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, Barnabas RV,  Hallett TB. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLOS ONE 2013;8:e54575.
  52. Chemaitelly H, Abu-Raddad LJ,  Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PLOS ONE 2013;8:e69803.
  53. Cuadros DF, Awad SF,  Abu-Raddad LJ. Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa. International Journal of Health Geographics 2013;12:28.
  54. Mohamoud YA, Mumtaz GR, Riome S, Miller D,  Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infectious Diseases 2013;13:288.
  55. Case KK, Ghys PD, Gouws E, Eaton JW, Borquez A, Stover J, Cuchi P, Abu-Raddad LJ, Garnett GP,  Hallett TB. Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bulletin of the World Health Organization 2012;90:831-8. (Peer-reviewed Policy and Practice)
  56. Chemaitelly H, Cremin I, Shelton J, Hallett TB,  Abu-Raddad LJ. Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sexually Transmitted Infections 2012;88:51-7.
  57. Gouws E, Cuchi P,  on behalf of the International Collaboration on Estimating HIV Incidence by Modes of Transmission (inlcluding Laith J. Abu-Raddad). Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sexually Transmitted Infections 2012;88:i76-i85.
  58. Cuadros D,  Abu-Raddad LJ. From individuals to populations: Immunological and epidemiological significance of co-infection in the dynamics of HIV. Clinical & Cellular Immunology 2012;S7:003 (Invited Review)
  59. Delva W, Wilson DP, Abu-Raddad LJ, Gorgens M, Wilson D, Hallett TB,  Welte A. HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLOS Medicine 2012;9:e1001239. (Peer-reviewed Invited Review)
  60. Mushlin AI, Christos PJ, Abu-Raddad LJ, Chemaitelly H, Deleu D,  Gehani AR. The importance of diabetes mellitus in the global epidemic of cardiovascular disease: the case of the State of Qatar. Transactions of the American Clinical and Climatological Association 2012;123:193-208. (Invited Contribution)
  61. Hallett TB, Alsallaq RA, Baeten JM, Weiss H, Celum C, Gray R,  Abu-Raddad LJ. Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sexually Transmitted Infections 2011;87:88-93.
  62. Mumtaz G, Hilmi N, Akala FA, Semini I, Riedner G, Wilson D,  Abu-Raddad LJ. HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa. Sexually Transmitted Infections 2011;87:101-6.
  63. Tanton C, Abu-Raddad LJ,  Weiss HA. Time to refocus on HSV interventions for HIV prevention? The Journal of Infectious Diseases 2011;204:1822-6. (Editorial)
  64. Alsallaq RA, Schiffer JT, Longini IM, Jr., Wald A, Corey L,  Abu-Raddad LJ. Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2. Sexually Transmitted Diseases 2010;37:290-7.
  65. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, Tawil O,  Wilson D. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010;24 Suppl 2:S5-23.
  66. McFarland W, Abu-Raddad LJ, Mahfoud Z, DeJong J, Riedner G, Forsyth A,  Khoshnood K. HIV/AIDS in the Middle East and North Africa: new study methods, results, and implications for prevention and care. AIDS 2010;24 Suppl 2:S1-4. (Editorial)
  67. Abu-Raddad LJ. HIV prevention policy in the Middle East and North Africa: Entangled dilemmas. Nature Middle East 2010; DOI:10.1038/nmiddleeast.2010.229. (Invited commentary)
  68. Abu-Raddad LJ, Schiffer JT, Ashley R, Mumtaz G, Alsallaq RA, Akala FA, Semini I, Riedner G,  Wilson D. HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics 2010;2:173-82.
  69. Mumtaz G, Hilmi N, Zidouh A, El Rhilani H, Alami K, Gouws E, Ghys P,  Abu-Raddad LJ. HIV mode of transmission analysis in Morocco 2010. Morocco Ministry of Health & Joint United Nations Programme on HIV/AIDS; 2010.
  70. Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wilson D,  Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC. The World Bank Press; 2010.
  71. Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wilson D,  Tawil O. Policy Notes. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC. The World Bank Press; 2010.
  72. Alsallaq RA, Cash B, Weiss HA, Longini IM, Jr., Omer SB, Wawer MJ, Gray RH,  Abu-Raddad LJ. Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level. Epidemics 2009;1:139-52.
  73. Sawires S, Birnbaum N, Abu-Raddad LJ, Szekeres G,  Gayle J. Twenty-five years of HIV: lessons for low prevalence scenarios. Journal of Acquired Immune Deficiency Syndrome 2009;51 Suppl 3:S75-82. (Invited Contribution)
  74. Abu-Raddad LJ,  Longini IM, Jr. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008;22:1055-61.
  75. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Jr., Self SG,  Corey L. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLOS ONE 2008;3:e2230.
  76. Hallett TB, Singh K, Smith JA, White RG, Abu-Raddad LJ,  Garnett GP. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLOS ONE 2008;3:e2212.
  77. Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ,  Abu-Raddad LJ. Persisting with prevention: the importance of adherence for HIV prevention. Emerging Themes in Epidemiology 2008;5:8. (Peer-reviewed Analytic Perspective)
  78. Abu-Raddad LJ, Boily MC, Self S,  Longini IM, Jr. Analytic insights into the population level impact of imperfect prophylactic HIV vaccines. Journal of Acquired Immune Deficiency Syndromes 2007;45:454-67.
  79. Abu-Raddad LJ, Patnaik P,  Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006;314:1603-6.
  80. Nagata K, Hosaka A,  Abu-Raddad LJ. Mass of the nucleon in a chiral quark-diquark model (vol 72, pg 035208, 2005). Physical Review C 2006;73:-.
  81. Abu-Raddad LJ,  Kublin JG. HIV and malaria: A vicious cycle. Scitizen 2006; scitizen.com. (Invited Commentary)
  82. Abu-Raddad LJ. Thomas L. Friedman's The First Law of Petropolitics. Foreign Policy 2006;155:9. (Letter to the Editor)
  83. Nagata K, Hosaka A,  Abu-Raddad LJ. Mass of the nucleon in a chiral quark-diquark model. Physical Review C 2005;72:035208.
  84. Abu-Raddad LJ,  Ferguson NM. Characterizing the symmetric equilibrium of multi-strain host-pathogen systems in the presence of cross immunity. Journal of Mathematical Biology 2005;50:531-58.
  85. Abu-Raddad LJ,  Ferguson NM. The impact of cross-immunity, mutation and stochastic extinction on pathogen diversity. Proceedings of the Royal Society of London Series B-Biological Sciences 2004;271:2431-8.
  86. van der Ventel BIS, Abu-Raddad LJ,  Hillhouse GC. Quasifree ? photoproduction from nuclei and medium modifications of resonances. Physical Review C 2003;68:024601.
  87. Abu-Raddad LJ. Pion-nucleus optical potential valid up to the Delta-resonance region. Physical Review C 2002;66:-.
  88. Abu-Raddad LJ, Hosaka A, Ebert D,  Toki H. Path-integral hadronization for the nucleon and its interactions. Physical Review C 2002;66:-.
  89. Abu-Raddad LJ,  Piekarewicz J. Extracting the spectral function of ^{4}He from a relativistic plane-wave treatment. Physical Review C 2001;64:064616.
  90. Abu-Raddad LJ, Piekarewicz J, Sarty AJ,  Rego RA. Lessons to be learned from the coherent photoproduction of pseudoscalar mesons. Physical Review C 1999;60:054606.
  91. Abu-Raddad LJ,  Piekarewicz J. Quasifree kaon photoproduction from nuclei in a relativistic approach. Physical Review C 1999;61:014604.
  92. Abu-Raddad LJ, Piekarewicz J, Sarty AJ,  Benmerrouche M. Nuclear dependence of the coherent ? photoproduction reaction in a relativistic approach. Physical Review C 1998;57:2053-6.
  93. Jaeger H, Abu-Raddad LJ,  Wick DJ. TDPAC study of structural disorder in metamict zircon. Applied Radiation and Isotopes 1997;48:1083-9.
  94. Jaeger H,  Abu-Raddad LJ. Two-detector coincidence routing circuit for personal computer-based multichannel analyzer. Review of Scientific Instruments 1995;66:3069-70.

Global Burden of Diseases studies

  1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, Forouzanfour MH, Groeger J, Hanafiah KM, Jacobsen KH, James SL, MacLachlan J, Malekzadeh R, Martin NK, Mokdad AA, Mokdad AH, Murray CJ, Plass D, Rana S, Rein DB, Richardus JH, Sanabria J, Saylan M, Shahraz S, So S, Vlassov VV, Weiderpass E, Wiersma ST, Younis M, Yu C, El Sayed Zaki M,  Cooke GS. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;doi: 10.1016/s0140-6736(16)30579-7. Epub ahead of print.
  2. Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM, Mooney MD, Fraser MS, Sligar A, Salomon J, Larson HJ, Friedman J, Abajobir AA, Abate KH, Abbas KM, Razek MM, Abd-Allah F, Abdulle AM, Abera SF, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Abyu GY, Adebiyi AO, Adedeji IA, Adelekan AL, Adofo K, Adou AK, Ajala ON, Akinyemiju TF, Akseer N, Lami FH, Al-Aly Z, Alam K, Alam NK, Alasfoor D, Aldhahri SF, Aldridge RW, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Ali R, Alkerwi A, Alla F, Mohammad R, Al-Raddadi S, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Amberbir A, Amegah AK, Ammar W, Amrock SM, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV 2016;3:e361-87.
  3. Kyu HH, Pinho C, Wagner JA, Brown JC, Bertozzi-Villa A, Charlson FJ, Coffeng LE, Dandona L, Erskine HE, Ferrari AJ, Fitzmaurice C, Fleming TD, Forouzanfar MH, Graetz N, Guinovart C, Haagsma J, Higashi H, Kassebaum NJ, Larson HJ, Lim SS, Mokdad AH, Moradi-Lakeh M, Odell SV, Roth GA, Serina PT, Stanaway JD, Misganaw A, Whiteford HA, Wolock TM, Wulf Hanson S, Abd-Allah F, Abera SF, Abu-Raddad LJ, AlBuhairan FS, Amare AT, Antonio CA, Artaman A, Barker-Collo SL, Barrero LH, Benjet C, Bensenor IM, Bhutta ZA, Bikbov B, Brazinova A, Campos-Nonato I, Castaneda-Orjuela CA, Catala-Lopez F, Chowdhury R, Cooper C, Crump JA, Dandona R, Degenhardt L, Dellavalle RP, Dharmaratne SD, Faraon EJ, Feigin VL, Furst T, Geleijnse JM, Gessner BD, Gibney KB, et al. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatr 2016;170:267-87.
  4. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, Vollset SE, Ozgoren AA, Abdalla S, Abd-Allah F, Aziz MIA, Abera SF, Aboyans V, Abraham B, Abraham JP, Abuabara KE, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Adelekan A, Ademi Z, Adofo K, Adou AK, Adsuar JC, Ärnlov J, Agardh EE, Akena D, Khabouri MJA, Alasfoor D, Albittar M, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali MK, Ali R, Alla F, Lami FA, Allebeck P, AlMazroa MA, Salman RA-S, Alsharif U, Alvarez E, Alviz-Guzman N, Amankwaa AA, Amare AT, Ameli O, Amini H, Ammar W, Anderson HR, Anderson BO, Antonio CAT, Anwari P, Apfel H, Cunningham SA, Arsenijevic VSA, Artaman A, Asad MM, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71.
  5. Murray CJ, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Ackerman IN, Ademi Z, Adou AK, Adsuar JC, Afshin A, Agardh EE, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P, Almazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Ameh EA, Amini H, Ammar W, Anderson HR, Anderson BO, Antonio CA, Anwari P, Arnlov J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Avila MA, Awuah B, Bachman VF, Badawi A, Bahit MC, Balakrishnan K, Banerjee A, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Basu A, Basu S, Basulaiman MO, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015;386:2145-91.
  6. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, Davis A, Degenhardt L, Dicker D, Duan L, Erskine H, Feigin VL, Ferrari AJ, Fitzmaurice C, Fleming T, Graetz N, Guinovart C, Haagsma J, Hansen GM, Hanson SW, Heuton KR, Higashi H, Kassebaum N, Kyu H, Laurie E, Liang X, Lofgren K, Lozano R, MacIntyre MF, Moradi-Lakeh M, Naghavi M, Nguyen G, Odell S, Ortblad K, Roberts DA, Roth GA, Sandar L, Serina PT, Stanaway JD, Steiner C, Thomas B, Vollset SE, Whiteford H, Wolock TM, Ye P, Zhou M, Ãvila MA, Aasvang GM, Abbafati C, Ozgoren AA, Abd-Allah F, Aziz MIA, Abera SF, Aboyans V, Abraham JP, Abraham B, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
  7. Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, Wang H, Duber HC, Naghavi M, Dicker D, Dandona L, Salomon JA, Heuton KR, Foreman K, Phillips DE, Fleming TD, Flaxman AD, Phillips BK, Johnson EK, Coggeshall MS, Abd-Allah F, Abera SF, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Adeyemo AO, Adou AK, Adsuar JC, Agardh EE, Akena D, Al Kahbouri MJ, Alasfoor D, Albittar MI, Alcala-Cerra G, Alegretti MA, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allen PJ, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Arnlov J, Arsenijevic VS, Artaman A, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:1005-70.

Books, Book Chapters & Public Health Reports

  1. Awad SF, Ncube G, Xaba S, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zimbabwe. Republic of Zimbabwe: Ministry of Health and Child Care; 2014.
  2. Awad SF, Tambatamba BC, Kaonga A, Sgaier SK, Lau FK, Odawo P, Sundaram M, Mohamoud YA,  Abu-Raddad LJ. Assessment of voluntary medical male circumcision program efficiency gains through sub-population prioritization in Zambia. Republic of Zambia: Ministry of Community Development and Mother and Child Health; 2014.
  3. Bennani A, Latifi A, El Kettani A, Maaroufi A, Guezzar F, Alami K, El Rhilani H, El Omari B, Kouyoumjian PS, Haddad P,  Abu-Raddad LJ. National and Souss Massa Draa: HIV modes of transmission analysis in Morocco 2013. Morocco Ministry of Health & Joint United Nations Programme on HIV/AIDS; 2014.
  4. Abu-Raddad LJ, Sgaier SK,  Mumtaz GR. HIV response in the Middle East and North Africa: An epidemic and its policy dilemmas. In: Smith R, ed. Global HIV/AIDS Politics, Policy and Activism: Persistent Challenges and Emerging Issues. Washington DC: Praeger Publishers; 2013:143-68.
  5. Mumtaz G, Hilmi N, Zidouh A, El Rhilani H, Alami K, Gouws E, Ghys P,  Abu-Raddad LJ. HIV mode of transmission analysis in Morocco 2010. Morocco Ministry of Health & Joint United Nations Programme on HIV/AIDS; 2010.
  6. Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wilson D,  Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC. The World Bank Press; 2010.
  7. Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wilson D,  Tawil O. Policy Notes. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC. The World Bank Press; 2010.